Cleared Traditional

K933791 - PHILIPS ANGIOPRO RELEASE 2.1

K933791 is an FDA 510(k) clearance for PHILIPS ANGIOPRO RELEASE 2.1, manufactured by Philips Medical Systems North America, Inc.. The device is a Class 2 Radiology device with product code JAA cleared through the Traditional 510(k) pathway after a 110-day FDA review.

K933791 · Philips Medical Systems North America, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1993
Decision
110d
Days
Class 2
Risk

K933791 is an FDA 510(k) clearance for the PHILIPS ANGIOPRO RELEASE 2.1. Classified as System, X-ray, Fluoroscopic, Image-intensified (product code JAA), Class II - Special Controls.

Submitted by Philips Medical Systems North America, Inc. (Shelton, US). The FDA issued a Cleared decision on November 22, 1993 after a review of 110 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1650 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Philips Medical Systems North America, Inc. devices

FDA 510(k) Submission Details - K933791

510(k) Number K933791 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 04, 1993
Decision Date November 22, 1993
Days to Decision 110 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
3d slower than avg
Panel avg: 107d · This submission: 110d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JAA Device Classification - Class 2, Special Controls

Product Code JAA System, X-ray, Fluoroscopic, Image-intensified
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1650
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAA System, X-ray, Fluoroscopic, Image-intensified

All 189
Devices cleared under the same product code (JAA) and FDA review panel - the closest regulatory comparables to K933791.
EPIC (ELECTROPHYSIOLOGY IMAGING COMPUTER
K926560 · Fischer Imaging Corp. · May 1994
SHIMADZU DIGITAL SUBSTRACTION SYST DAR-2400 SERIES
K933472 · Shimadzu Corp. · Feb 1994
CATHETERIZATION C-ARM SUPPORT MH-51BM/MH-51CM
K933473 · Shimadzu Corp. · Nov 1993
EP-X
K934481 · Fischer Imaging Corp. · Nov 1993
SIRESKOP CX
K932445 · Siemens Medical Solutions USA, Inc. · Sep 1993
FLUOREX
K926122 · Toshiba America Medical Systems, In.C · Feb 1993